Insider Buying: Option Care Health (NASDAQ:OPCH) CEO Acquires 12,500 Shares of Stock

Key Points

• CEO John Charles Rademacher bought 12,500 shares on May 4 at an average price of $21.18 (≈$264,750), raising his holdings to 695,152 shares—a 1.83% increase—per an SEC filing.
• Option Care beat Q1 EPS estimates ($0.40 vs. $0.37) while revenue of $1.35B slightly missed expectations, and the company set FY2026 guidance of 1.820–1.920 EPS.
• Shares traded around $21.14 on heavy volume (7.2M vs. avg 2.14M) and sit well below the 50- and 200-day averages, while Wall Street’s consensus is a Moderate Buy with a $32.08 target price.

Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) CEO John Charles Rademacher purchased 12,500 shares of Option Care Health stock in a transaction dated Monday, May 4th. The shares were bought at an average price of $21.18 per share, with a total value of $264,750.00. Following the completion of the transaction, the chief executive officer owned 695,152 shares in the company, valued at approximately $14,723,319.36. This trade represents a 1.83% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Option Care Health Price Performance

Shares of OPCH stock traded up $1.11 during midday trading on Monday, reaching $21.14. 7,195,534 shares of the company traded hands, compared to its average volume of 2,140,592. The firm's 50 day simple moving average is $29.15 and its two-hundred day simple moving average is $30.74. Option Care Health, Inc. has a 1-year low of $18.01 and a 1-year high of $36.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07. The firm has a market cap of $3.32 billion, a PE ratio of 16.39, a price-to-earnings-growth ratio of 1.12 and a beta of 0.68.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings results on Thursday, April 30th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.37 by $0.03. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.39 billion. During the same period last year, the firm earned $0.40 EPS. The company's revenue for the quarter was up 1.3% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. On average, equities research analysts expect that Option Care Health, Inc. will post 1.69 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the company. Stephens set a $30.00 price objective on Option Care Health in a research report on Friday. Citizens Jmp restated a "market outperform" rating and set a $38.00 price objective (up from $36.00) on shares of Option Care Health in a research report on Tuesday, January 13th. Wall Street Zen downgraded Option Care Health from a "buy" rating to a "hold" rating in a research report on Saturday, February 28th. Citigroup restated an "outperform" rating on shares of Option Care Health in a research report on Tuesday, January 13th. Finally, Truist Financial set a $30.00 price objective on Option Care Health in a research report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $32.08.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Pacer Advisors Inc. acquired a new position in Option Care Health in the 3rd quarter valued at $593,000. Victory Capital Management Inc. raised its holdings in Option Care Health by 129.5% in the 3rd quarter. Victory Capital Management Inc. now owns 383,605 shares of the company's stock valued at $10,649,000 after acquiring an additional 216,489 shares during the last quarter. Geneva Capital Management LLC raised its holdings in Option Care Health by 27.6% in the 3rd quarter. Geneva Capital Management LLC now owns 1,369,862 shares of the company's stock valued at $38,027,000 after acquiring an additional 296,216 shares during the last quarter. Massachusetts Financial Services Co. MA increased its holdings in shares of Option Care Health by 2.7% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,244,321 shares of the company's stock worth $34,542,000 after buying an additional 33,019 shares during the last quarter. Finally, Game Creek Capital LP acquired a new stake in shares of Option Care Health during the 3rd quarter worth $1,527,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.

About Option Care Health

Option Care Health NASDAQ: OPCH is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry's most experienced home infusion businesses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.